AngioDynamics | ANGO - Sales Revenues


AngioDynamics reported $79.43M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 153.6M 12.4M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
ICU Medical USD 551.68M 25.91M Jun/2026
Inogen USD 74.93M 504K Sep/2024
J&J USD 25.31B 1.21B Jun/2026
Medtronic USD 9.8B 0 Jun/2026
Merit Medical Systems USD 418.8M 36.9M Jun/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Smiths GBP 1.44B 133M Jan/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Terumo JPY 311.81B 11.49B Jun/2026
Trinity Biotech USD 11.07M 3.24M Dec/2025